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ABSTRACT
Blood transfusion can be very beneficial and life saving to patients; though it carries with it the risk of Transfusion 
Transmissible Infections [TTIs] likes the Human Immuno deficiency Virus [HIV], Hepatitis B Virus [HBV], 
Hepatitis C Virus [HCV] and Syphilis. Unfortunately, many hospitals in Nigeria are unable to undertake adequate 
donor-blood screening for TTIs using the ELISA Technique, owing to lack of facilities, manpower and/or funding. 
As our center partners with the National Blood Transfusion Service [NBTS] for screening with ELISA, we set out to 
determine the prevalence of the TTIs among blood donors in order to underscore the desirability of optimal 
screening of blood and partnering with the NBTS to improve blood safety. Donor blood units were sent to the NBTS 
for rescreening with ELISA technique, after we had screened for the TTIs using rapid kits. We then reviewed the 
results of 613 donors over two years to determine the prevalence of TTIs among donors. Overall results showed that 
86 (13.6%) was reactive for one or two of the TTIs: HIV 23(3.6%); HBV 41 (6.5%); HCV 17 (2.7%) and Syphilis
5(0.8%). Our findings suggest that screening donor blood with rapid kits only is froth with dangers to the patient;
hence hospitals lacking the capacity to screen with ELISA should partner with the NBTS.
. 
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INTRODUCTION 
Modern medical interventions can bring significant 
benefits to patients but they also carry inevitable risks 
of adverse events that can- and too often do- happen 
[WHO, 2002]. Blood transfusion is an essential and 
life saving support within the health care system. Yet 
the quality and safety of blood transfusion therapy 
continue to be threatened particularly in developing 
countries by inadequate supply of blood and blood 
products, risk of Transfusion Transmissible 
Infections (TTIs), Laboratory Technical errors and 
errors in the administration of blood and blood 
components [WHO 2008].
Blood transfusion remain a very effective medium of 
transmitting the Human Immunodeficiency Virus 
types I and II (HIV I& II), Hepatitis B Virus (HBV), 
Hepatitis C Virus (HCV), Syphilis and other known 
TTIs and those that may emerge (Orkuma, 2014). 
The World Health Organization therefore 
recommended that member states should screen 
blood meant for transfusion purposes for a minimum
of four TTIs, namely HIV I&II, HBV, HCV and 
Syphilis. Screening for other TTIs like Chagas 
disease, Malaria and so on are also recommended for 
member states where these agents pose significant 
risk to blood transfusion (WHO, 2008). Member 
states are also encouraged to establish national blood 
systems based on Voluntary Non-Remunerated Blood 
Donors (VNRBD) for the provision of blood and 
blood components in their various countries (WHO, 
2011). Nigeria has adopted these recommendations in 
her National Health Policy and the National policy on 
Blood Transfusion (FMOH, 2004; 2005)
The National Blood Transfusion Service (NBTS) in 
Nigeria was formally commissioned in 2005 
followed by the launching of the revised National 
policy on blood transfusion in 2006. Over the years,
this service have progressively improved her effort at 
providing adequate, safe and timely blood for 
Nigerians, as recommended by the WHO, but the 
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efforts have grossly fallen short of national need. The 
estimated national need for blood is 1.4-1.7 million;
unfortunately much less is collected by the NBTS 
and of these, only ten percent are from VNRBDs 
(Awute, 2015). Hospitals have therefore resorted to 
other sources of blood to support the service 
provision mainly through Family/Replacement 
donors and often Commercial or paid donors who 
masquerade as family members for blood bank staff. 
The prevalence of the TTIs is higher amongst these 
categories of donors than amongst VNRBDs; making 
it imperative for hospitals to properly screen their 
blood supplies before transfusion. Unfortunately 
however, hospitals have to rely on rapid test kits for 
the screening of their blood supply for TTIs as many 
hospitals, including our own hospital, Irrua Specialist 
Teaching Hospital, Irrua Edo State Nigeria, do not 
have facilities for screening for the TTIs using the 
Enzyme-Linked Immuno-Sorbent Assay (ELISA) 
technique. Therefore very many hospitals in the 
country still use the rapid kits to screen donor blood 
for transfusion uses; a practice that is associated with 
the dangers of increasing the burden of the TTIs in 
the population because of the poorer sensitivity of the 
method compared to ELISA technique as 
demonstrated in studies and recommended minimum 
standards by the WHO (WHO, 2013; Orkuma, 2014).
In view of the forgoing, our hospital partnered with 
the NBTS South-South Zonal Center in Benin in the 
Hospital Linkage Program of the service. One 
component of this program is the Blood Rotation 
Program in which units of donor blood collected in 
the hospital, and which were initially screened and 
found none reactive for any of the TTIs are taken to 
the NBTS Benin Center for screening for the TTIs 
using ELISA technique before returning same to the 
hospital for patient’s use. We then undertook a 
retrospective survey of our data over a two years 
period to;
a. Determine the disparity between rapid test kit-
screened and ELISA Technique screened blood 
and hence, the prevalence of TTIs amongst 
blood donors in our center.
b. Underscore the imperativeness of screening 
donor blood for TTIs using ELISA, or even 
more advanced techniques such as Nucleic Acid 
Testing (NAT) if we are to reduce to the barest 
minimum the incidence of TTIs in blood 
recipients in our hospitals.
c. Underscore the imperativeness of partnership 
with the NBTS in their HLP for hospitals that 
are yet unable to acquire the capability to screen 
blood meant for transfusion using ELISA 
techniques. 
MATERIALS AND METHODS
Sample Size: This comparative / retrospective study 
involved the evaluation of a total of 631 blood 
sample units. 
Routine Rapid Sample Screening: Prospective 
blood donors in our blood bank are routinely 
screened for HIV I&II, HBV, HCV and Syphilis 
using the rapid test kits before being bled if their 
blood was satisfied non- reactive. These units of 
donor blood will then be sent to the NBTS South-
South Zonal center in Benin City, Edo State, Nigeria,
for re-screening with the ELISA Technique. Usually, 
the DetermineTM HIV-1/2 rapid kit is used to screen 
for HIV I&II while Skytec rapid kits manufactured 
by Skytec Medicals USA, is used to screen for 
Hepatitis B Surface Antigen (HBsAg), antibodies to 
HCV and Syphilis. The manufacturers’ instructions 
in the products are routinely followed during the 
screening with the rapid test kits.
Blood Re-Screening Techniques: In partnership 
with NBTS, blood units are re-screened using the 
second algorithm (combo-Antigen and antibody) 4th
generation ELISA technique with STATFAX-2600
washer and STATFAX-2100 reader (Awareness 
Technology); Biorad Genscreen Ultra HIV Ag-Ab 
was used for HIV I & II screening, Biorad Monolisa 
HBsAg ULTRA was used for HBsAg screening 
while HCV and Syphilis were screened using Dia.Pro 
Diagnostic Bioprobes. After re-screening, the NBTS 
returns the non-reactive blood units with results of all 
units sent to them. Subsequently, these results are 
evaluated. 
Retrospective Data Collection: A retrospective 
study of our records from January 2013 to December 
2014 was conducted to determine the prevalence of 
HIV, HBV, HCV and Syphilis amongst donor blood 
that was sent to the NBTS for re-screening. A total of 
Six Hundred and Thirty one units of donor blood 
were involved. We collated the returned TTI status of 
donor blood for two years and analyzed it.
Data Analysis: Comparative percentages were 
calculated for the data collected within the period 
under review as shown in table 1   
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RESULTS
Blood re-screening results by NBTS indicated that 
out of the 631 (largely family replacement cum 
commercial donors masquerading as family) donor 
samples, 86 (13.6 %) were reactive for one, or two of 
the TTIs. The pattern of reactivity for the TTIs were 
23 (3.6 %) for HIV, 41 (6, 5 %) for HBV, 17(2.7%)
for HCV and 5 (0.8 %) for Syphilis as shown in 
Table 1 below. Fifty (50) donors were positive for 
only one or the other of the TTIs mostly HBV while 
Nine (09) were positive for both two of the TTIs. 
Two of the later were positive for the pairs of 
HIV/HCV and HCV/Syphilis; with three (3) being 
positive for the combination of HBV/HCV, while one
(1) each was positive for the combination of 
HIV/HBV and HBV/Syphilis. None of the donors 
were positive for three or four TTIs. Overall, the 
prevalence of HIV amongst our donors was 3.6%.
Table 1: Positivity for TTIs
TTIs Number of Positive 
Samples
Percentage of positive 
Samples
HIV 23 3.6 %
HBV 41 6.5 %
HCV 17 2.7 %
Syphilis 5 0.8 %
Total Reactive Samples 86 13.6 %
DISCUSSION
The observed prevalence of HIV among the donor-
blood units examined (3.6%) is comparable to the 
3.24% observed among family replacement donors 
by the NBTS nationally, but higher than 1 % (Ejele et 
al., 2005) amongst donors in Port-Harcourt. This 
could be because the Port-Harcourt donors consist of 
a substantial number of Voluntary Non-Remunerated 
Blood Donors (VNRBDs) amongst them. The 
calculated prevalence of HBV in this study is 6.5% 
which is lower than the 9.75% but much higher than 
2.99% found by the NBTS amongst FRBDs and 
regular VNRBDs respectively. This further 
underscores the fact that regularly VNRBDs are the 
safest in terms of risk of transmission of any of the 
TTIs.
Furthermore, the Sero-prevalence of HCV amongst 
our donors was 2.7% which is much higher than 
0.5% found in blood donors by Erhabor et al. (2006)
in Port Harcourt. It is also higher than the 0.8% and 
0.2% found amongst Commercial and Family 
replacement donors respectively by Erhabor et al. 
(2006). Interestingly, our figure is higher than the 
1.37% found in Regular VNRBDs by the NBTS. This 
is most likely because the pre-donation interview of 
donors is more thorough in Port Harcourt than it is in 
ours center thus calling for a review of our pre-
donation donor screening for better results. It also 
underscores the inevitability of obtaining donor blood 
from only VNRBDs if we aim to ensure supply of 
safe and cost effective blood to our patients. The 
sero-prevalence for Syphilis amongst our donors was 
0.8% which is comparable to 0.69% but higher than 
0.34% obtained by the NBTS, while the sero-
prevalence for all the TTIs amongst our donors was 
13.6%. This figure is comparable to 17.6% obtained 
by the NBTS amongst FRBDs but higher than 5.41% 
found amongst regular VNRBDS by the NBTS. A 
VNRBD is one who gives blood, plasma or cellular 
component of blood of his/her own freewill and 
receives no payment for it, either in the form of cash, 
or in kind which could be considered a substitute for 
money. This would include time off work other than 
that reasonably needed for the donation and travel. 
Small tokens, refreshments and reimbursements of 
direct travel costs are compatible with voluntary non 
remunerated donation. 
Family replacement donation on the other hand often 
lead to coercion and place undue burden on patients’ 
family and friends to give blood. This often leads to 
systems of hidden payments as is applicable to some 
of our donors because relations of patients will 
simply tell you that a commercial donor is their 
relation and of course, there is no easy way of 
knowing better. Indeed, inadequate blood supplies in 
developing countries exert pressure on caregivers and 
blood banks, which in most cases, induces sharp 
practices. Even outright commercialization and 
racketeering of blood donation is froth with 
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exploitation of donors who frequently have high risk 
behaviors for infection with the TTIs. 
Several studies have also shown that the safest blood 
for transfusion is that donated by VNRBDs and based 
on this, the WHO recommended that high priority be 
given to the elimination of family/replacement and 
paid donor systems which are associated with a 
significantly higher prevalence of TTIs. The body 
further recommended that the education, motivation, 
recruitment and retention of VNRBD populations 
who donate blood regularly, should be the foundation 
of a safe and adequate national blood supply. Whilst 
the NBTS is in place in the country, their operations 
have been unable to meet the National need for blood 
leaving hospitals to source for blood elsewhere with 
its attendant risks to patients and health workers. 
The current situation calls for strengthening NBTS to 
be able to meet the National need for blood, or at 
least substantially reduce the wide gap between the 
demand and supply of blood. The improvement in 
transfusion practices in our hospitals through
capacity building for proper donor selection and 
deferral is recommended. We believe that absolute
safe blood transfusion is possible but through 
infrastructural/facility upgrades and the training and 
retraining of personnel.
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